Mylan Antitrust Suit Over Acne Drug Rejected By 3rd Circ.
The Third Circuit on Wednesday affirmed a Pennsylvania federal court's dismissal of Mylan's antitrust suit over the acne medication Doryx, finding that the generics maker failed to establish that Warner Chilcott...To view the full article, register now.
Already a subscriber? Click here to view full article